Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

1yr ago Cannabis greenmarketreport Views: 295

-

Village Farms International Inc. (Nasdaq: VFF) completed its previously announced registered direct offering with certain institutional investors for the purchase and sale of an aggregate of 18,350,000 common shares at $1.35 per share, together with accompanying warrants to purchase up to 18,350,000 common shares, which have an exercise price of $1.65 per share.

The stock closed on Monday at $1.01 per share but was selling higher by one cent on Tuesday in early trading.

Village Farms said that it has raised approximately $25 million before deducting placement agent fees and other offering expenses payable by Village Farms. The net proceeds from this offering will be used for general working capital purposes.

It’s been a tough market for cannabis companies to raise money. Viridian Capital Advisors wrote this week that cannabis capital raises are off to a multiyear low. Viridian says that only $5.9 million had closed through the first three weeks of the year compared to $157.2 million last year. Of that amount, public companies have raised 56.7% of total capital year-to-date.

CEO Dilution

As a result of the offering, the company noted that founder and CEO Michael DeGiglio’s ownership of Village Farms was diluted below 10% of Village Farms’ issued and outstanding common shares. Prior to the offering he owned roughly 11.4% of the issued and outstanding common shares of Village Farm.

DeGiglio continues to beneficially own 9,259,529 common shares of Village Farms and vested stock options exercisable for 1,180,722 common shares of Village Farms, collectively representing approximately 9.4% of the issued and outstanding common shares of Village Farms.

The company also noted that because DeGiglio now owns or exercises control or direction over less than 10% of the issued and outstanding common shares of Village Farms, he is no longer subject to ongoing early warning reporting requirements under applicable Canadian securities laws in respect of his ownership of Village Farms.

The warrants will be exercisable beginning on July 30, 2023, and will expire on July 30, 2028. Proceeds from the exercise of all the warrants would be approximately $30 million over this period.

In November, Village Farms reported its financial results for the third quarter ending Sept. 30, 2022, as consolidated sales dropped by 2% to $71.1 million from $72.4 million in the 2021 third quarter. The consolidated net loss was ($8.7 million), or ($0.10) per share compared with a net income of $0.8 million), or $0.01 per share. This also missed the estimates for an earnings loss of ($0.09).

Last month the company announced that its subsidiary, Pure Sunfarms, began shipping cannabis products for the Israeli medical market under an exclusive three-year supply agreement with Israel-based Dr. Samuelov Importing and Marketing Ltd., doing business as Better Pharma.

Village Farms Raises $25 Million in Tight Capital Markets on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.